Psychiatric drug developer Seaport applies for US IPO, seeking to raise over 200 million dollars

According to a filing submitted by the Boston-based company to the U.S. Securities and Exchange Commission (SEC) on Monday, the company plans to issue 11.8 million shares, with each share priced between $16 and $18. Based on the upper limit of this range and the outstanding shares listed in the filing, the biotechnology company's market capitalization will reach $912 million. According to a presentation, the IPO is expected to be priced on April 30.